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Introduction
Dientamoeba fragilis is an enteric trichomonad parasite that is found within the gastrointestinal tracts of humans and has been linked to various clinical manifestations (Barratt et al., 2011a) . However the parasite's pathogenic potential is yet to be fully resolved, (Barratt et al., 2011a; Barratt et al., 2011b; Röser et al., 2013; Sarafraz et al., 2013; Stark et al., 2010) . The parasite's biology, life cycle, animal reservoirs and transmission pathways are all poorly defined (Barratt et al., 2011a) .
Although the mode of transmission of D. fragilis is yet to be determined, there are two theories proposed; transmission via a helminth transport vector (Enterobius vermicularis) or direct transmission via the faecal-oral route (Barratt et al., 2011a) . Animal hosts have been implicated in the transmission of enteric protozoa and are possible sources of human infections (Esch and Petersen, 2013; Ruaux and Stang, 2014; Smith et al., 2009) . Dientamoeba has been reported in several animal species with the first report outside of humans documented in wild monkeys from the Philippines in 1930 (Hegner and Chu, 1930) . Later studies found D. fragilis in captive macaques (Knowles and DasGupta, 1936) , sheep (Noble and Noble, 1952) and baboons (Myers and Kuntz, 1968) . Recent studies have also reported the parasite in several non-human primates, pigs, sheep and rodents (Cacciò et al., 2012; Helenbrook et al., 2015; Ogunniyi et al., 2014; Stark et al., 2011; Stark et al., 2008) . However, only two of these studies utilised molecular techniques (Cacciò et al., 2012; Stark et al., 2008) .
Traditionally, diagnostic methods for detection of D. fragilis have relied on microscopic examination of faecal material. However, several conventional and real-time PCR (RT-PCR) assays have been described in the literature that are considered more sensitive and specific, and are now considered the gold-standard for detecting D. fragilis (Röser et al., 2013; Stark et al., 2011) .
The aim of this study was to evaluate two RT-PCR assays and a nested conventional PCR assay with particular attention to assay specificity, for the detection of D. fragilis in animal samples (Cacciò et al., 2012; Stark et al., 2014; Verweij et al., 2007) .
Materials and methods

Sample Collection and DNA extraction
This study was performed at St Vincent's Hospital, Sydney. A total of 420 animal stool samples were collected and DNA extracted using a Bioline Isolate faecal DNA kit (Bioline, Australia) as previously described (Roberts et al., 2013) . Animal faecal samples included 37 distinct animal species collected from several different locations in Australia over a two-year period (Roberts et al., 2013) . Additionally, pig faecal samples collected from Western Australia used in a previous study were also included (Armson et al., 2009 ). All extracted DNA obtained for this study was stored at -20 °C until required for molecular analysis.
Nested PCR
A nested conventional PCR was performed amplifying a 366 bp fragment of the 18S rRNA gene of D. fragilis as previously described in the literature (Cacciò et al., 2012) . Amplified PCR products were analysed by gel electrophoresis on pre-cast E-gel ® EX 2% (Life Technologies, Australia) as per manufacturer's instructions.
Real-time PCR
A previously published RT-PCR amplifying a 98 bp fragment of the 5.8S rRNA gene using a MGB-Taqman probe was performed as described in the literature (Verweij et al., 2007) . Each 
Easyscreen TM PCR
Animal samples that were analysed using an EasyScreen TM Enteric Protozoan Detection Kit (Genetic Signatures, Australia) and were run in accordance to manufacturer's instructions. This multiplex PCR assay contained both an extraction control and an internal positive control to detect PCR inhibitors. Inhibited samples were diluted 1 in 5 with molecular biology grade H2O and then retested.
Sensitivity
To determine the limit of detection for all PCR assays, cultured D. fragilis trophozoites previously isolated from a symptomatic patient were counted using KOVA ® Glasstic® Slides (ThermoFisher Scientific). A negative faecal sample was spiked with a solution containing a 550,000 D. fragilis cells per mL. This sample was then diluted in phosphate buffered saline (PBS) for a series of 1:10 dilutions. The samples having D. fragilis trophozoite concentrations ranging from 5,500 to 0.55 cells were subjected to DNA extraction for assessment of assay sensitivity.
Testing was performed in triplicate.
Specificity Controls
Specificity experiments were undertaken using DNA extracted from several trichomonads (Table 1 ). All assays were tested against these trichomonads to determine the suitability of the assays in relation to animal studies.
Results
Sensitivity Results
The sensitivity of all molecular assays was tested to determine the limit of detection. All three assays were able to detect 5 D. fragilis trophozoites. Reproducibility experiments conducted showed all assays consistently detected down to 5 trophozoites per ml of liquid stool.
Specificity Assay
To determine the specificity of each assay the real-time PCR and nested PCRs were tested against several trichomonads closely related to D. fragilis (Table 1) trophozoites per ml. Lower concentrations of P. hominis failed to produce a product.
Prevalence of D. fragilis DNA in Animal samples
Given its excellent specificity, the EasyScreen assay was selected to further survey the animal samples (Table 3) . A total of 420 samples were analysed for the presence of D. fragilis DNA.
Two (0.5%) samples from two different species, a dog and cat, were positive for D. fragilis ( Figure   3 ).
The extraction control failed in 9/420 samples and 11/420 samples were found to contain inhibitors. Repeat testing of these samples following dilution failed to resolve the inhibition problem. These 20 (5%) samples were excluded from the final analysis.
Discussion
Several molecular tests, including real-time PCR and nested PCR have been used in clinical and epidemiological studies for the detection of D. fragilis from faecal samples, and molecular tests are considered the gold standard (Röser et al., 2013; Stark et al., 2014; Verweij et al., 2007) .
However, while these assays were evaluated on human clinical samples, no experiments were undertaken to assess the suitability of these for the testing of animal samples. Furthermore, it is imperative that the widest possible range of organisms is used to assess assay specificity. As such, this study assessed the specificity of each test
In this study, three molecular diagnostic assays were evaluated for their suitability when mobilensis has been reported in laboratory mice, squirrels and monkeys (Culberson et al., 1988; Kamaruddin et al., 2014) , while H. acosta has been reported in several reptiles and amphibians including the indigo snake, rattle snake, gila monster, neotropical tree boa, calabar ground boa, rough-scaled sand boa, forest tree frog and monitor lizard (Ceza et al., 2015; Lee and Pierce, 1960) .
The non-specific amplification observed in this study for two commonly used D. fragilis diagnostic PCR assays impedes their applicability for both and animal studies. Given that the EasyScreen assay was the only test available that could differentiate D. fragilis from other trichomonads, this assay was then used to test the 420 animal samples collected from various species. The assay detected D. fragilis in a cat and dog faecal sample. Due to the nature of the commercial assay used, sequencing of the amplicons was not possible. As part of the EasyScreen assay protocol the DNA undergoes a 3 base conversion via a patented sodium bisulfite conversion process that chemically alters all cytosine bases to thymine (Stark et al., 2014) . This confounds sequence identification, particularly for short amplicons resulting from real-time PCR.
This is the first study to detect D. fragilis DNAin dog and cat stool specimens. Previously, only one study has explored D. fragilis infection in kittens (Knoll and Howell, 1945 . The overall prevalence of D. fragilis from animals tested in this study was 0.48%; this is in vast contrast to what has recently been reported from humans with prevalence's ranging upwards of 50% (Stark et al., 2016) . No animal studies have been performed on dogs to date with the only established animal model for D. fragilis described in rodents, with chronic infections established both in mice and rats (Munasinghe et al., 2013) .
Close relationships between humans and companion animals such as dogs and cats poses risks, as companion animals are potential sources of human infection with enteric zoonotic protozoa (Fletcher et al., 2012; Thompson and Smith, 2011) . Parasites such as Blastocystis sp., Giardia intestinalis and Cryptosporidium sp. infect animals and are considered zoonosis (Ng et al., 2011; Parkar et al., 2007) . Zoonotic transmission of Blastocystis sp. is supported by the presence of genetically identical Blastocystis subtypes in humans and animals. Furthermore, prevalence rates as high as 70.8% have been reported in dogs and 67.3% in cats (Duda et al., 1998) .
Studies have also genotyped a diverse range of Blastocystis subtypes (from animals which also occur in humans (namely ST1, 2, 4, 5 and 6) (Parkar et al., 2010; Parkar et al., 2007; Wang et al., 2013) . Giardia intestinalis, assemblages A and B are potentially zoonotic, and considered transmissible between pets and pet owners, with pooled international prevalence rates of 15.2% in dogs and 12% in cats (Bouzid et al., 2015; Feng and Xiao, 2011) . In Australia, one study reported G. intestinalis infections in 9.4% of dogs and 2% in cats (Palmer et al., 2008) . In this same study,
Cryptosporidium was reported in 0.6% of dog and 2.4% of cat samples surveyed (Palmer et al., 2008) . The possibility of reverse zoonosis cannot be ruled out and the animals that tested positive for D. fragilis may have become infected from humans. Unfortunately, the presence or absence of symptoms in the animals examined in this study could not be determined as no clinical information was available at time of collection. Given that rodents can become chronically infected with Dientamoeba, we also cannot rule out the possibility that infection of these animals may have occurred via ingestion of an infected rodent.
Interestingly, there was no evidence for D. fragilis infection in the pig samples (0/136) surveyed in this study. Previous studies from Italy detected D. fragilis in swine with prevalence rates as high as 43.8% (Cacciò et al., 2012; Crotti et al., 2007) . These studies utilised microscopy, nested PCR, real-time PCR and sequencing for detection and subsequent confirmation of D.
fragilis infection in these pigs. However, the current study indicates that the assays used to detect D. fragilis in swine non-specifically amplified DNA from closely related trichomonads. Most notably, the PCR assays in question both cross reacted with T. foetus, a parasite commonly found in the intestines of pigs. This indicates that a degree of caution should be taken when using these assays, though this does not discredit the study by Cacciò et al., who confirmed the presence of D.
fragilis from both humans and pigs by sequencing of the amplicons. 
